1
For Private Circulation Only
Technical and Derivatives Review
|July 31, 2020
Nifty snaps six-week winning streak, still 11000 defended successfully
Sensex (37607) / Nifty (11073)
Source: Trading View
Future outlook
This week, the market started the proceedings on a sluggish note in the absence of any trigger on the domestic as well as global
front. On the following day, we witnessed a good broad-based rally to mark fresh 4-months high beyond the 11300 mark. However,
the way things looked at the end of Tuesday’s session, it just turned out to be an illusion in the remaining part of the week. Although
there were a couple of attempts made around 11300, the market was unable to display the strength in a similar fashion. As a result,
we witnessed some profit taking in the latter part of the week to conclude around the lower end of the weekly range.
Market finally snapped its six-week winning streak due to some weakness around 11300. However, the damage is not big and hence,
as of now should only be interpreted as a profit booking after a relentless rally. Towards the end of the week, we were seeing 11050
as a key support; but the way markets behaved on Friday around it, this does not appear to be an important support. Hence, we
would rather extend the range slightly on downside and would observe key supports around 10950-10870 for the forthcoming
week. In case if profit booking extends towards these mentioned levels, it should still be considered as a corrective move and not
the actual trend reversal. In our sense, the actual weakness would start only if Nifty sustains below 10870 and hence, till then one
should continue with a stock specific positive bias. However, on the flipside, 11300-11350 has also become a strong ceiling and the
fresh leg of the rally would only unfold above this. Till then traders are advised to remain light within a slightly bigger range of 10870
– 11350.
For the early part of the week, 11200-11250 should be considered as an immediate resistance zone. The banking space has been the
weakest link and the way it’s placed, the directional move in benchmark would mainly be triggered by the banking stocks only.
Hence, all eyes would be on it. Apart from this, the entire Pharma space has been once again on a roll after a brief pause and there
were some other sectoral movers also, that kept buzzing and bucking the trend. So, the pragmatic approach would be to focus on
individual stocks till the time market remains in the above-mentioned range.
2
For Private Circulation Only
Technical and Derivatives Review
|July 31, 2020
FII’s carry long positions in new series
Nifty spot closed at 11073.45 this week, against a close of 11194.15 last week. The Put-Call Ratio has decreased from 1.74 to 1.31.
The annualized Cost of Carry is positive at 2.73%. The Open Interest of Nifty Futures has decreased by 17.62%.
Derivatives View
Nifty current month future closed with a premium of 22.40 points against a discount of 15.95 points to its spot. Next month future is
trading at a premium of 26.40 points.
As far as Nifty options activities are concerned, the weekly expiry options witnessed open interest addition in 11200, 11300 and
11500 call options whereas put options of 11000 and below strikes too added some open interest at the start of the new series.
Maximum open interest for the coming weekly series is at 11500 call and 11000 put options.
During the week, Nifty surpassed the 11300 mark, however it failed to sustain above that and witnessed some correction around
expiry to end the week with a loss of over a percent. The rollover in Nifty is at 77.59 percent, which is in line with its 3-month
average of 77.40 percent, whereas rollover in Bank Nifty is at 75.30 percent v/s its average of 79 percent. FII’s have carried more of
their long positions to the new series and their ‘Long Short’ Ratio in index futures segment is tad over 66 percent. The weekly
options data indicates support around 11000 mark and resistance at 11200-11300. If we look at the sector specific build up, it is
seen that the stocks from the Cement and the Pharma sector have added good amount of long positions which have
been rolled too. So, traders should look for stocks from these sectors for short term trading opportunities.
Weekly change in OI
Short Formation
Scrip
OI
Futures
Chg (%)
Price
Price
Chg(%)
UBL 1247400 25.05 953.50 (4.67)
CHOLAFIN
7567500
14.31
199.65
(5.36)
MANAPPURAM
21414000
9.44
159.40
(11.42)
RECLTD
19680000
6.53
100.65
(5.58)
ICICIBANK
135396250
5.80
348.75
(8.82)
Long Formation
Scrip
OI
Futures
OI
Chg (%)
Price
Price
Chg(%)
CIPLA 14478100 17.19 723.70 8.75
APOLLOHOSP
1246500
13.68
1663.70
10.15
AUROPHARMA
14441700
11.90
879.0
5
8.50
TORNTPHARM
2010500
9.36
2678.30
14.97
SUNPHARMA
32944800
8.46
532.15
9.74
3
For Private Circulation Only
Technical and Derivatives Review
|July 31, 2020
Research Team Tel: 022 - 39357600 (Extn – 6844) Website: www.angelbroking.com
For Technical & Derivative Queries E-mail: [email protected]
DISCLAIMER
Angel Broking Limited (hereinafter referred to as “Angel”) is a registered Member of National Stock Exchange of India Limited, Bombay
Stock Exchange Limited and Metropolitan Stock Exchange Limited. It is also registered as a Depository Participant with CDSL and
Portfolio Manager and Investment Adviser with SEBI. It also has registration with AMFI as a Mutual Fund Distributor. Angel Broking
Limited is a registered entity with SEBI for Research Analyst in terms of SEBI (Research Analyst) Regulations, 2014 vide registration
number INH000000164. Angel or its associates has not been debarred/ suspended by SEBI or any other regulatory authority for
accessing /dealing in securities Market. Angel or its associates/analyst has not received any compensation / managed or co-managed
public offering of securities of the company covered by Analyst during the past twelve months.
This document is solely for the personal information of the recipient, and must not be singularly used as the basis of any investment
decision. Nothing in this document should be construed as investment or financial advice. Each recipient of this document should make
such investigations as they deem necessary to arrive at an independent evaluation of an investment in the securities of the companies
referred to in this document (including the merits and risks involved), and should consult their own advisors to determine the merits
and risks of such an investment.
Reports based on technical and derivative analysis center on studying charts of a stock's price movement, outstanding positions and
trading volume, as opposed to focusing on a company's fundamentals and, as such, may not match with a report on a company's
fundamentals. Investors are advised to refer the Fundamental and Technical Research Reports available on our website to evaluate the
contrary view, if any.
The information in this document has been printed on the basis of publicly available information, internal data and other reliable
sources believed to be true, but we do not represent that it is accurate or complete and it should not be relied on as such, as this
document is for general guidance only. Angel Broking Limited or any of its affiliates/ group companies shall not be in any way
responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report.
Angel Broking Limited has not independently verified all the information contained within this document. Accordingly, we cannot
testify, nor make any representation or warranty, express or implied, to the accuracy, contents or data contained within this document.
While Angel Broking Limited endeavors to update on a reasonable basis the information discussed in this material, there may be
regulatory, compliance, or other reasons that prevent us from doing so.
This document is being supplied to you solely for your information, and its contents, information or data may not be reproduced,
redistributed or passed on, directly or indirectly.
Neither Angel Broking Limited, nor its directors, employees or affiliates shall be liable for any loss or damage that may arise from or in
connection with the use of this information.
Technical and Derivatives Team:
Sameet Chavan Chief Analyst – Technical & Derivatives sameet.cha[email protected]ng.com
Ruchit Jain Senior Analyst - Technical & Derivatives ruchit.jai[email protected].com
Rajesh Bhosale Technical Analyst rajesh.bhosl[email protected]ng.com
Sneha Seth Derivatives Analyst [email protected]gelbroking.com